New Chapter, has introduced its inaugural Liquid Multivitamin, aligning with the growing consumer demand for convenient and comprehensive nutritional solutions. This product offers 45% more nutrients than leading competitors, including fermented B vitamins, Vitamin C, Vitamin K, and superfoods, supporting various aspects of health such as heart, bone, brain, immune function, and digestion.

Designed for the entire family, the Liquid Multivitamin provides age-specific dosing for adults and children aged two and up, available in two flavours: Orange Mango and Mixedberry. The flavours were developed by expert sensory scientists to ensure a pleasant taste experience without excessive sweetness.

In line with New Chapter’s commitment to quality and sustainability, the product is IGEN Non-GMO Tested, 100% vegan, gluten-free, and free from chemical preservatives like potassium sorbate. The packaging is made from 100% post-consumer recycled plastic, reflecting the brand’s dedication to eco-friendly practices.

The Liquid Multivitamin is now available in 30oz bottles starting at $48 on NewChapter.com, with broader retail availability forthcoming at Whole Foods Market, The Vitamin Shoppe, and local health food stores nationwide. Recommended daily dosages are 1.5 teaspoons for ages 2-3, 1 tablespoon for ages 4-13, and 2 tablespoons for those 14 and older.

This launch comes when the global liquid dietary supplements market is experiencing significant growth, driven by increasing consumer awareness of health and wellness, and a preference for easy-to-consume nutritional products. The market was valued at $21.56 billion in 2023 and is projected to grow at a CAGR of 11.6% from 2024 to 2030.

Heart disease remains a leading cause of death worldwide, with risk factors such as high blood pressure, poor cholesterol levels, and inflammation contributing to cardiovascular complications.

Pycnogenol is a standardized extract from Pinus pinaster bark, rich in procyanidins, flavonoids, and phenolic acids. These bioactive compounds contribute to its strong antioxidant, anti-inflammatory, and vasodilatory effects, making it a valuable ally for heart health.

Scientific research has demonstrated Pycnogenol’s potential benefits in improving endothelial function, reducing blood pressure, supporting healthy cholesterol levels, and enhancing blood circulation—key factors in maintaining cardiovascular wellness.

Scientific Evidence: Pycnogenol’s Impact on Heart Health

1. Supports Healthy Blood Pressure

Hypertension is a major risk factor for heart disease, and Pycnogenol has shown promise in managing blood pressure levels.

A meta-analysis of 24 randomized controlled trials (RCTs) involving 1,594 participants found that Pycnogenol supplementation significantly reduced:

• Systolic blood pressure by 2.54 mmHg
• Diastolic blood pressure by 1.76 mmHg

These findings suggest Pycnogenol may contribute to heart health by promoting better blood vessel function and reducing strain on the cardiovascular system.

2. Improves Cholesterol Levels

Maintaining a healthy lipid profile is crucial for preventing heart disease. The same meta-analysis found that Pycnogenol supplementation resulted in:

• A 7.12 mg/dL reduction in low-density lipoprotein (LDL, “bad” cholesterol)
• A 3.27 mg/dL increase in high-density lipoprotein (HDL, “good” cholesterol)

These changes suggest that Pycnogenol may help balance cholesterol levels, potentially reducing the risk of plaque buildup in the arteries.

3. Enhances Endothelial Function

The endothelium—the inner lining of blood vessels—plays a critical role in cardiovascular health. Poor endothelial function can lead to arterial stiffness and an increased risk of heart disease.

A double-blind, placebo-controlled study found that daily supplementation with 200 mg of Pycnogenol for eight weeks improved endothelial function in patients with coronary artery disease, increasing flow-mediated dilation (FMD) from 5.3% to 7.0% (P < 0.0001). This improvement was attributed to Pycnogenol’s ability to reduce oxidative stress and enhance nitric oxide production, leading to better blood vessel relaxation and circulation.

4. Regulates Blood Sugar and Metabolism

Metabolic health is closely linked to heart disease. Pycnogenol has been shown to help regulate blood sugar levels, which is especially beneficial for individuals with diabetes or metabolic syndrome.

The meta-analysis reported that Pycnogenol supplementation resulted in:

• 5.86 mg/dL reduction in fasting blood glucose
• 0.29% decrease in glycated hemoglobin (HbA1c, a marker of long-term blood sugar control)

Additionally, Pycnogenol contributed to a 0.47 kg/m² reduction in body mass index (BMI), indicating a potential role in weight management—another key factor in heart health.

How You Can Support Pycnogenol Sales

With increasing consumer demand for natural heart health solutions, you can position Pycnogenol as a science-backed supplement for cardiovascular support. Here’s how:

• Educate Customers: Highlight Pycnogenol’s benefits for blood pressure, cholesterol, circulation, and metabolic health.
• Offer Quality Products: Ensure that Pycnogenol supplements meet clinical dosage recommendations (typically 100-200 mg daily).
• Encourage Consultation: Advise customers to consult healthcare professionals, especially those on medication for blood pressure, diabetes, or cholesterol.

Understanding Pycnogenol’s role in heart health can empower retailers to provide valuable insights to customers seeking natural cardiovascular support. With a growing body of scientific evidence demonstrating its benefits, Pycnogenol stands out as a natural, effective option for promoting heart wellness.

A Science-Backed Intervention for Substance Use Disorders

Addiction remains a significant public health crisis, with millions struggling to overcome substance dependence. While traditional treatments such as cognitive-behavioural therapy (CBT) and medication-assisted therapy (MAT) have shown success, researchers are increasingly exploring adjunctive therapies to enhance recovery outcomes.

One promising compound is N-acetylcysteine (NAC), a derivative of the amino acid L-cysteine. NAC has demonstrated potential in mitigating cravings, reducing withdrawal symptoms, and supporting brain recovery in individuals struggling with addiction. This article explores the scientific basis, clinical evidence, and therapeutic potential of NAC in substance use disorders.

The Mechanisms Behind NAC’s Role in Addiction

1. Regulation of Glutamate Homeostasis

Neurobiological research has established that addiction dysregulates glutamate, the brain’s most abundant excitatory neurotransmitter. This disruption contributes to drug-seeking behaviour, cravings, and relapse. NAC helps restore glutamate homeostasis, particularly in the nucleus accumbens, a brain region implicated in reward processing.

2. Dopamine Modulation and Craving Reduction

Substance use depletes dopamine levels, leading to compulsive drug-seeking behaviour. NAC has been shown to increase extracellular dopamine, potentially reducing cravings and improving impulse control.

3. Antioxidant and Neuroprotective Effects

Chronic substance use induces oxidative stress and neuroinflammation, which can damage neurons and contribute to cognitive impairment. NAC, a precursor to glutathione (GSH), is a potent antioxidant that protects against neurotoxicity and supports neuronal repair.

Clinical Evidence: NAC’s Impact on Different Addictions

Nicotine Addiction

A randomized controlled trial (RCT) found that individuals receiving NAC (2,400 mg/day) experienced a significant reduction in cigarette cravings compared to placebo (Knackstedt et al., 2009). NAC’s ability to normalize glutamate signalling may explain its potential to promote smoking cessation.

Cocaine and Methamphetamine Dependence

Clinical studies indicate that NAC reduces cue-induced cravings in cocaine-dependent individuals. A meta-analysis by Schmaal et al. (2020) reported that NAC (2,400 mg/day) reduced relapse rates and improved cognitive flexibility, critical for sustaining abstinence.

Cannabis Use Disorder

A double-blind, placebo-controlled study on adolescents with cannabis dependence revealed that NAC (1,200 mg/day) increased quit rates compared to placebo (Gray et al., 2012). The compound’s ability to modulate glutamate levels and reduce withdrawal symptoms may be key to its effectiveness.

Alcohol Use Disorder (AUD)

Chronic alcohol consumption contributes to oxidative damage and neuroinflammation, exacerbating withdrawal symptoms and relapse risk. A study by Berk et al. (2013) demonstrated that NAC (1,200–2,400 mg/day) decreased alcohol cravings and improved cognitive function in individuals with AUD.

Opioid Addiction

Preliminary research suggests NAC may attenuate withdrawal symptoms and opioid-induced neurotoxicity. Though more studies are needed, early findings suggest potential benefits in reducing opioid cravings and enhancing treatment outcomes when used alongside MAT.

Recommended Dosage and Administration

Administration: NAC should be taken in divided doses (600 mg, 2–4 times per day) to maintain stable plasma levels.

Safety Profile and Considerations

NAC is generally well-tolerated, with mild side effects such as nausea, diarrhea, and headaches. However, certain populations should exercise caution:

• Patients on blood thinners: NAC may have mild anticoagulant effects, increasing bleeding risk.
• Individuals with chronic illnesses: Those with liver or kidney disease should consult a healthcare provider before use.
• Not a standalone treatment: While promising, NAC should be used with behavioural therapy and medical supervision for optimal results.

NAC as an Adjunctive Therapy in Addiction Recovery

In conclusion, the emerging body of research highlights NAC as a valuable adjunctive treatment for substance use disorders. Its ability to modulate neurotransmitter balance, reduce oxidative stress, and mitigate cravings makes it a compelling option for individuals seeking to overcome addiction.

Future research should focus on long-term clinical trials to refine dosage recommendations and assess NAC’s efficacy across different stages of addiction recovery. As the field of addiction medicine evolves, N-acetylcysteine stands out as a promising, science-backed intervention with the potential to enhance traditional treatment approaches.

References

1. Berk, M., Copolov, D. L., Dean, O., et al. (2013). N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial. Biological Psychiatry, 64(5), 361-368.
2. Gray, K. M., Carpenter, M. J., Baker, N. L., et al. (2012). N-Acetylcysteine in Adolescent Marijuana Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Psychiatry, 169(8), 805-812.
3. Knackstedt, L. A., LaRowe, S., & Kalivas, P. W. (2009). The Role of Glutamate in Nicotine and Cocaine Addiction: Treatment Implications. Annals of the New York Academy of Sciences, 1141(1), 262-275.
4. Schmaal, L., Veltman, D. J., Nederveen, A., et al. (2020). N-Acetylcysteine for the Treatment of Cocaine Dependence: A Systematic Review. Addiction Biology, 25(3), e12797.

L-theanine, an amino acid predominantly found in tea leaves (Camellia sinensis), has been extensively studied for its potential neuropsychiatric benefits. Recent research continues to support its role in enhancing cognitive function, reducing stress and anxiety, and providing neuroprotective effects.

Cognitive Function and Mood Enhancement

A 2019 randomized controlled trial investigated the effects of L-theanine on stress-related symptoms and cognitive functions in healthy adults. Participants who received L-theanine supplementation for four weeks exhibited significant improvements in verbal fluency and executive function, along with reductions in stress-related symptoms such as depression, anxiety, and sleep disturbances. These findings suggest that L-theanine can enhance cognitive performance and alleviate stress-related symptoms in healthy individuals.

Further supporting these results, a 2021 study focused on middle-aged and older adults found that a single dose of L-theanine improved attention and working memory. Participants demonstrated faster reaction times and increased accuracy in cognitive tasks, indicating that L-theanine may enhance cognitive functions related to attention and memory in this age group.

Neuroprotective Properties

Beyond cognitive enhancement, L-theanine has shown potential neuroprotective effects. A study exploring its impact on dopamine-induced neurotoxicity revealed that L-theanine provides protection against oxidative stress-induced neuronal damage. This neuroprotection is partly attributed to the upregulation of glutathione, an antioxidant, suggesting that L-theanine may help safeguard neurons from oxidative damage.

Immune System Support

Emerging evidence indicates that L-theanine may play an immunomodulatory role. Cell and animal studies have demonstrated that L-theanine can influence immune responses by regulating the function of γδT lymphocytes, enhancing glutathione synthesis, and modulating the secretion of cytokines and neurotransmitters. These effects suggest that L-theanine could support immune function and contribute to overall health.

Safety and Dosage

L-theanine is generally considered safe for consumption. A recent study evaluated the safety and efficacy of AlphaWave® L-theanine supplementation over 28 days and found it to be well-tolerated, with significant reductions in perceived stress among participants.

Commonly studied dosages range from 200 mg to 400 mg per day, with no significant adverse effects reported.

Recent studies continue to support the beneficial effects of L-theanine on cognitive function, stress reduction, neuroprotection, and immune modulation. Its safety profile and potential health benefits make it a valuable supplement for individuals seeking to enhance mental performance and overall well-being.

Condition-Based Merchandising Strategy for L-Theanine

You have go beyond general product placement and adopt a health condition-based merchandising strategy for L-Theanine. This approach aligns products with customer needs, improving conversion rates and enhancing customer education. Given that L-Theanine is already within the brain health, stress management, and cognitive enhancement category, retailers should refine their strategy by grouping products based on specific health conditions and consumer concerns.

Key Health Conditions & Consumer Pain Points

1. Stress & Anxiety Management
   • Consumer Profile: Individuals experiencing daily stress, occasional anxiety, or mood fluctuations.
   • Merchandising Strategy:
     • Feature L-Theanine in a “Stress & Anxiety Support” section alongside ashwagandha, GABA, rhodiola, and magnesium glycinate.
     • Use clear messaging: “Support a calm, focused mind without drowsiness.”
     • Place near herbal adaptogens and non-drowsy calming aids to capture consumers seeking alternative solutions.
2. Cognitive Function & Focus
   • Consumer Profile: Students, professionals, and aging adults looking for mental clarity, memory retention, and concentration.
   • Merchandising Strategy:
     • Position L-Theanine in a “Cognitive Support” section with nootropics like phosphatidylserine, bacopa monnieri, and omega-3s.
     • Cross-merchandise with caffeine-free energy solutions for professionals and students seeking focus without overstimulation.
     • Messaging: “Enhance focus, memory, and mental clarity—without jitters.”
3. Sleep & Relaxation
   • Consumer Profile: Consumers looking for sleep support without next-day grogginess.
   • Merchandising Strategy:
     • Merchandise L-Theanine in a “Sleep & Relaxation” section with melatonin, valerian root, and magnesium.
     • Promote L-Theanine’s synergy with non-habit-forming sleep aids.
     • Messaging: “Promotes relaxation and better sleep—without dependency.”
4. Mood & Emotional Well-Being
   • Consumer Profile: Those experiencing mood fluctuations or low energy linked to stress.
   • Merchandising Strategy:
     • Place L-Theanine in a “Mood Support” section alongside 5-HTP, SAMe, and saffron extract.
     • Offer educational signage explaining how L-Theanine supports neurotransmitter balance for emotional stability.
     • Messaging: “Helps maintain a balanced mood and emotional resilience.”
5. Brain Aging & Neuroprotection
   • Consumer Profile: Older adults and individuals interested in long-term brain health.
   • Merchandising Strategy:
     • Integrate L-Theanine into a “Healthy Brain Aging” section with curcumin, lion’s mane mushroom, and acetyl-L-carnitine.
     • Highlight its antioxidant and neuroprotective properties in supporting long-term cognitive health.
     • Messaging: “Protect brain function and support long-term cognitive health.”

2. In-Store Merchandising Execution

Shelf Adjacency & Cross-Merchandising:

• Place L-Theanine near condition-specific solutions, not just in the general “Brain Health” category.
• Create bundles for condition-based health concerns (e.g., Stress & Focus Pack: L-Theanine + Magnesium + Adaptogens).

Endcaps & Educational Displays:

• Highlight clinical studies supporting its benefits using QR codes leading to research-backed articles.
• Use signage like:
  • “Struggling with stress? L-Theanine supports a calm, clear mind.”
  • “Looking for focus without caffeine? Try L-Theanine.”

Consultation & Staff Training:

• Train staff on L-Theanine’s role in neurotransmitter balance, stress reduction, and cognitive enhancement so they can recommend it to customers looking for targeted solutions.

Sampling & Consumer Experience Stations:

• If available in liquid or tea form, provide samples in-store to increase trial and conversion rates.
• Include consumer testimonials near product displays.

3. E-Commerce Merchandising Execution

Category-Specific Landing Pages:

• Create dedicated pages like:
  • “L-Theanine for Stress & Anxiety”
  • “L-Theanine for Focus & Cognitive Performance”
  • “L-Theanine for Sleep & Relaxation”
• Optimize for SEO with condition-based search terms (e.g., “L-Theanine for anxiety relief,” “L-Theanine for focus enhancement”).

Personalized AI Recommendations:

• Integrate “Frequently Bought Together” product suggestions based on customer browsing history.

Subscription & Loyalty Incentives:

• Offer auto-ship discounts for ongoing cognitive and stress support.
• Provide exclusive educational content for subscribers.

Digital Marketing & Content Strategy:

• Publish condition-focused blog posts, such as:
  • “L-Theanine vs. Other Stress Relief Supplements: What Works Best?”
  • “The Science Behind L-Theanine and Focus Enhancement”
• Run Google Ads & Meta Ads targeting searches related to stress relief, focus, and sleep.

4. Promotional Strategy for Higher Engagement

Seasonal & Health Condition-Based Promotions:

• Back-to-School & Exam Season: Focus on cognitive function and memory.
• End-of-Year Burnout Period: Emphasize stress and anxiety relief.
• Mental Health Awareness Month: Highlight L-Theanine’s mood and relaxation benefits.

Bundle Discounts & Exclusive Offers:

• Cross-promotional pricing with complementary products.
• Offer multi-buy discounts for long-term use.

Retail Events & Expert-Led Workshops:

• Host “Ask a Nutritionist” events in-store or via live webinars featuring L-Theanine’s health benefits.
• Offer limited-time product trials for new customers.

You can increase sales and consumer trust by aligning L-Theanine with condition-specific solutions rather than treating it as a general cognitive supplement. A strategic mix of targeted in-store placement, condition-driven marketing, personalized e-commerce experiences, and health-focused promotions will ensure L-Theanine is positioned as a valuable, science-backed solution for stress relief, cognitive function, and long-term brain health.

Sprouts Farmers Market, Inc. (Nasdaq: SFM) has reported a robust financial performance for the fourth quarter and full year ending December 29, 2024, underscoring its strategic positioning in the health-focused grocery sector.

Fourth Quarter 2024 Highlights:

• Net Sales: $2.0 billion, an 18% increase from the same period in 2023.
• Comparable Store Sales Growth: 11.5%.
• Diluted Earnings Per Share (EPS): $0.79, up from $0.49 in Q4 2023.
• New Store Openings: 12 additional locations.

Full Year 2024 Highlights:

• Net Sales: $7.7 billion, reflecting a 13% increase from 2023.
• Comparable Store Sales Growth: 7.6%.
• Diluted EPS: $3.75, a significant rise from $2.50 in the prior year.
• Store Expansion: 33 new stores, bringing the total to 440 across 24 states.

CEO Jack Sinclair attributed this success to the company’s unique, attribute-driven offerings that resonate with health-conscious consumers. He stated, “Our teams across the business delivered on our strategy and set us up for even greater success in the future.”

Despite these strong financial metrics, Sprouts’ stock experienced a 2.34% decline over the past month. This downturn aligns with broader market trends, as major indices like the Dow and Nasdaq faced similar declines, influenced by a mix of poor earnings results and economic data.

Looking ahead, Sprouts projects continued growth in 2025 with plans to open at least 35 new stores. The company anticipates net sales growth between 10.5% and 12.5%, comparable store sales growth of 4.5% to 6.5%, and adjusted diluted EPS ranging from $4.52 to $4.68.

In terms of financial health, Sprouts ended 2024 with $265 million in cash and cash equivalents, zero balance on its $700 million revolving credit facility after a $125 million voluntary paydown, and authorized a new $600 million share buyback program.

This performance reflects Sprouts Farmers Market’s effective strategy and strong market position in the competitive grocery industry.

Wellness is more than a trend—it’s a lifestyle—Viva Wellness 2025 is set to be the go-to event for brands looking to connect with health-conscious consumers in a meaningful way.

Digital engagement has taken brands far, but nothing replaces real-life interactions. Consumers want to see, touch, and experience products firsthand. They seek authentic connections, expert insights, and a deeper understanding of what they’re investing in for their well-being. That’s exactly what Viva Wellness 2025 is designed to deliver.

Why Be Part of Viva Wellness 2025?

• Engage Directly with Consumers – Move beyond social media and create real connections that turn interest into loyalty.
• Showcase Your Brand’s Expertise – Educate, inspire, and build trust with a highly engaged audience actively seeking solutions.
• Be Part of the Future of Wellness – Join leading international experts and brands shaping the next wave of health and well-being.
• Gain Exclusive Marketing Exposure – Benefit from multi-channel promotional support, putting your brand in front of thousands of potential customers.

Want to Learn More?

We’re inviting forward-thinking brands to be part of this game-changing event. To receive the full exhibitor prospectus and explore how Viva Wellness 2025 can help you bridge the gap from digital to real-world engagement, email us today (olivier@vivamagonline.com).

This is your opportunity to be at the heart of the wellness conversation. Let’s connect, inspire, and make an impact together.

The Kroger Co. (NYSE: KR) has announced the appointment of David Kennerley as its incoming Chief Financial Officer (CFO), effective 3 April 2025. Kennerley, currently Senior Vice President (SVP) and CFO for PepsiCo Europe, will succeed Todd Foley, who has served as interim CFO.

Kennerley will join Kroger on 10 March 2025 as Senior Vice President, working alongside Foley through the end of Kroger’s fiscal year 2024 reporting cycle. Foley will remain with the company as SVP and a member of the senior leadership team, supporting the transition through Kroger’s first quarter.

Smooth Transition Reflects Strong Succession Planning

Rodney McMullen, Kroger’s Chairman and CEO, emphasised the company’s commitment to a seamless leadership transition.

“Consistent with Kroger’s history of thoughtful succession planning, David and Todd will transition seamlessly to ensure Kroger continues to deliver on its go-to-market strategy, providing access to fresh, affordable food for families across America and, by doing so, creating long-term shareholder value,” said McMullen.

This leadership change comes as Kroger continues to focus on driving growth, enhancing operational efficiencies, and delivering value to shareholders.

Todd Foley to Retire from Interim CFO Role After More Than Two Decades at Kroger

With this transition, Todd Foley will step down from his interim CFO role but remain with Kroger’s senior leadership team. McMullen expressed gratitude for Foley’s service and dedication.

“On behalf of our board of directors and senior management team, we thank Todd for stepping into the interim CFO role last year and ensuring the business did not skip a beat,” McMullen stated. “Todd’s contributions to our business and the finance department are wide and deep, and I especially appreciate his care for and commitment to his fellow associates. I wish Todd and his family all the best in the next chapter of their lives.”

Foley’s tenure at Kroger spans more than two decades. He joined the company in 2001 as an audit manager and advanced through several leadership roles, including Vice President and Treasurer (2013), Vice President and Corporate Controller (2017), and Group Vice President and Corporate Controller (2021). Foley became interim CFO in 2024.

Outside Kroger, Foley serves on the board of the Connetic Venture Capital Access Fund and the Board of Advisors for Star Engineering, LLC.

David Kennerley Brings Extensive Global Finance Experience to Kroger

David Kennerley, an accomplished financial leader with nearly 25 years at PepsiCo, brings a wealth of experience spanning U.S. and international markets.

“We look forward to welcoming David to the Kroger team,” said McMullen. “He brings to Kroger deep experience leading a broad cross-section of U.S. and international finance teams, which helped PepsiCo create shareholder value for nearly 25 years.”

Kennerley’s career with PepsiCo began in 2001 in the International Corporate Finance/Treasury Department, managing treasury activities for Western Europe. He later held key leadership roles, including Senior Finance Director for PepsiCo’s Global Beverages Group and SVP Finance for North American Bottling. In 2020, he was named CFO for PepsiCo Europe.

Kennerley expressed excitement for his new role:

“I’m thrilled to be joining Kroger at this exciting time for the business. I look forward to getting started and building on the strong legacy built by Todd and the team. I want to thank PepsiCo for the incredible opportunities I’ve had over the last 24 years. These experiences have been instrumental in paving the way for my new role as the CFO of Kroger.”

Background and Relocation to Cincinnati

Kennerley holds a degree from University College London and is a qualified chartered accountant, having begun his career at Arthur Andersen. He and his family will relocate to Cincinnati as he assumes his new position.

Strategic Leadership for Kroger’s Future Growth

Kennerley’s appointment marks a strategic step for Kroger as the company continues to advance its business strategy, focusing on customer experience, operational excellence, and shareholder value creation.

This leadership transition aligns with Kroger’s long-term vision, ensuring continuity while bringing fresh perspectives from a global leader in the consumer goods sector.

Global sports icon and undefeated boxing legend Floyd Mayweather is stepping into a new ring: performance nutrition. With the launch of his premium supplements line, 101 (One of One), Mayweather brings his championship mindset to the world of wellness. Developed in partnership with supplement experts Magnum Nutraceuticals and guided by entertainment powerhouse WME, this brand isn’t just about supplements—it’s about self-improvement, commitment, and excellence.

“This brand is built to cut through the clutter and give everyone a trusted option,” said Mayweather, co-founder of 101. “I don’t cut corners in the gym, and I won’t cut corners with my nutrition. 101 is designed to deliver results—period.”

A Champion’s Philosophy Meets Cutting-Edge Formulations

The launch of 101 marks Mayweather’s first foray into the wellness market, transforming his passion for fitness into a brand that embodies his drive for peak performance. From the boxing ring to the boardroom, Mayweather’s business ventures—including Mayweather Boxing + Fitness and Mayweather Promotions—centre on empowering individuals to push past their limits.

His entry into the supplements space is no different. With seven premium products formulated for men and women, 101 offers science-backed support for fitness enthusiasts and elite athletes alike.

Introducing the 101 (One of One) Product Line-Up:

• Whey Protein Powder 
  High-quality protein to fuel muscle growth and speed up recovery. Includes prebiotic fibre and digestive enzymes for easy digestion and maximum absorption.
• Sport Pre-Workout 
  A fast-acting blend of NeuroRush and electrolytes to boost stamina, focus, and performance.
• Loaded Pre-Workout
  Designed for serious athletes, with 8g of Citrulline to maximize endurance and energy.
• Creatine Monohydrate 
  Clean, pure ingredients to increase strength and power, plus long-term cognitive and muscle health benefits.
• Greens + Gut Health 
  Over four servings of fruits and vegetables, plus prebiotic fibre for gut support and immune health.
• Hydration 
  On-the-go electrolyte stick packs with taurine to combat fatigue and cramps.
• Peptide Builder 
  Advanced muscle-building capsules powered by PeptiStrong® and DL185™ to promote recovery and fight muscle loss.

A Trusted Collaboration for Champions

The 101 brand is built on a foundation of expertise and trust, thanks to Mayweather’s partnership with Magnum Nutraceuticals, a leader in high-quality supplements for over 20 years.

“Floyd Mayweather’s unmatched work ethic made this collaboration a natural fit,” said Bill Russell, CEO of Magnum Nutraceuticals. “Together, we’ve created a brand that reflects our shared passion for performance and results.”

The Mayweather Standard: Excellence Without Compromise

Floyd Mayweather’s career has been defined by his relentless pursuit of greatness—and that same standard applies to 101 (One of One). Each product is crafted with premium ingredients and scientific formulations to support athletes at every level of their journey.

As Mayweather himself says, “This isn’t just a supplements line. It’s a reflection of my mindset. It’s about pushing past limits—because champions are made by what they do when no one’s watching.”

A new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE) has found that while life expectancy for people with HIV (PWH) in British Columbia, Canada has improved dramatically over the past few decades, women with HIV continue to experience significantly lower life expectancy gains than men.

The study, published in The Lancet Public Health, analysed data from 1996 to 2020 and found that although both men and women have benefited from advances in HIV treatment, the gap in life expectancy between the sexes has widened rather than narrowed. This disparity highlights ongoing socio-economic and healthcare barriers that disproportionately affect women living with HIV.

HIV Treatment Successes, But a Growing Gender Divide

Since 2012, British Columbia has intensified its efforts to combat HIV through the expansion of the Seek and Treat for Optimal Prevention of HIV/AIDS Program (STOP HIV/AIDS). This initiative has led to increased HIV testing, earlier treatment, and improved access to care, resulting in substantial life expectancy gains for people with HIV.

However, the benefits have not been equal. According to the study:

• Life expectancy for men with HIV at age 20 increased from 44 years (1996–2001) to 68 years (2012–2020).
• Life expectancy for women with HIV at age 20 rose from 42 years (1996–2001) to 61 years (2012–2020)—a much smaller increase.
• The life expectancy gap at ages 20 and 40 widened over time, indicating that improvements in healthcare access and treatment have not translated equally across genders.

Dr. Katherine W. Kooij, the study’s lead author, expressed concern about the findings.

“The good news is that both men and women with HIV are living longer, healthier lives thanks to safe and effective HIV treatments available at no cost in British Columbia. However, we initially expected that the life expectancy gap between men and women with HIV would narrow over time. Instead, it has grown.”

Dr. Kooij and her colleagues suspect that socio-structural factors such as healthcare barriers, poverty, housing instability, and stigma may explain why women with HIV continue to face poorer health outcomes.

Women with HIV at Higher Risk of Non-Communicable Diseases

One of the key findings of the study was that women with HIV are 33% more likely to die from non-communicable diseases—including kidney, liver, and lung diseases—compared to men with HIV. This remained true even after accounting for age, socio-economic factors, and past HIV-related health issues.

The research also showed that women with HIV are more likely to live in lower-income neighbourhoods. In the study:

• 12.3% of women with HIV lived in Vancouver’s Downtown Eastside—a neighbourhood known for high rates of unemployment, housing instability, mental health challenges, and substance use. In contrast, only 7.1% of men with HIV lived in this area.
• Women were more likely to report injection drug use as a risk factor for HIV transmission and were more likely to meet the criteria for substance use disorder.

These findings align with a larger Canada-wide study that showed women with HIV are more likely to experience food insecurity, lower income, weaker social support, and discrimination compared to women without HIV.

Additionally, the ongoing opioid crisis in British Columbia has had a disproportionate impact on women with HIV, further contributing to lower life expectancy.

The BC-CfE’s study underscores the need for urgent action to close the life expectancy gap for women with HIV.

“While we continue researching the causes of these disparities, immediate steps must be taken to support women with HIV,” said Dr. Kooij. “Low-barrier healthcare, better housing, and stronger community connections are crucial to improving health outcomes for women.”

The study also emphasizes the importance of screening and prevention efforts for non-communicable diseases among women with HIV. Chronic illnesses, often overlooked in HIV care, are becoming the leading causes of death in this population.

“The life expectancy gap between men and women with HIV should be narrowing—not getting worse,” added Dr. Kooij.

Key Study Insights

• The study included 11,738 men (82.2%) and 2,534 women (17.8%) with HIV, all aged 20 or older.
• Life expectancy was measured at ages 20, 40, and 55 over three periods: 1996–2001, 2002–2011, and 2012–2020.
• The findings contrast with global trends, where women typically outlive men in the general population.

About the BC Centre for Excellence in HIV/AIDS

The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment, and education centre, internationally recognized for its leadership in combating HIV/AIDS. It pioneered the Treatment as Prevention® (TasP®) strategy, which has influenced global targets, including UNAIDS’ 95-95-95 goal to end the HIV pandemic by 2030.

Beyond HIV, the BC-CfE applies its Targeted Disease Elimination® approach to areas such as viral hepatitis and addiction, working closely with government agencies, healthcare providers, researchers, and communities to improve health outcomes across Canada and globally.

Final Thoughts

This study is a stark reminder that progress in HIV treatment does not automatically translate to equal outcomes for all. While medical advancements have significantly extended life expectancy for people with HIV in British Columbia, women continue to face systemic barriers that limit their ability to benefit fully.

Closing this gap requires a comprehensive approach—one that goes beyond medical care to address the social determinants of health affecting women with HIV. By tackling issues such as housing instability, economic insecurity, and healthcare access, policymakers and healthcare providers can help ensure that all people living with HIV have an equal chance at a longer, healthier life.